4
|
Safaie Qamsari E, Safaei Ghaderi S, Zarei B, Dorostkar R, Bagheri S, Jadidi-Niaragh F, Somi MH, Yousefi M. The c-Met receptor: Implication for targeted therapies in colorectal cancer. Tumour Biol 2017; 39:1010428317699118. [DOI: 10.1177/1010428317699118] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
c-Met (mesenchymal–epithelial transition factor) is a tyrosine kinase receptor activated by hepatocyte growth factor and regulates multiple biological processes, such as cell scattering, survival, and proliferation. Aberrant c-Met signaling has been implicated in a variety of cancer types, including colorectal cancer. c-Met is genetically altered through various mechanisms that is associated with colorectal cancer progression and metastasis. Especially, in colorectal cancer, preclinical evidence for the aberrant activation of the c-Met signaling exists. Accordingly, molecular targeting of c-Met receptor could be a promising strategy, in the treatment of colorectal cancer patients. Recently, it was also shown that crosstalk between c-Met and other cell surface receptors attributes to tumorigenesis and development of therapeutic resistance. Characterization of the molecular mechanisms through which c-Met crosstalks with other receptors in favor of tumor formation and progression remains to explore. This review will describe the mechanisms of aberrant c-Met signaling in colorectal cancer and discuss on additional roles for c-Met receptor through crosstalk with other tyrosine kinase receptors and cell surface proteins in colorectal cancer. Novel therapeutic approaches for c-Met pathway targeting will also be discussed.
Collapse
Affiliation(s)
- Elmira Safaie Qamsari
- Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Sepideh Safaei Ghaderi
- Department of Biotechnology, Faculty of Advanced Science & Technology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran
- Hybridoma Laboratory, Immunology Department, Pasteur Institute of Iran, Tehran, Iran
| | - Bahareh Zarei
- Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
| | - Ruhollah Dorostkar
- Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
| | - Salman Bagheri
- Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Farhad Jadidi-Niaragh
- Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
| | - Mohammad Hossein Somi
- Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Mehdi Yousefi
- Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| |
Collapse
|
9
|
Jagoda EM, Bhattacharyya S, Kalen J, Riffle L, Leeder A, Histed S, Williams M, Wong KJ, Xu B, Szajek LP, Elbuluk O, Cecchi F, Raffensperger K, Golla M, Bottaro DP, Choyke P. Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [
99m
Tc] (AH-113018) or CY 5** (AH-112543) Labeled Peptide. Mol Imaging 2015. [DOI: 10.2310/7290.2015.00023] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Affiliation(s)
- Elaine M. Jagoda
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Sibaprasad Bhattacharyya
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Joseph Kalen
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Lisa Riffle
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Avrum Leeder
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Stephanie Histed
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Mark Williams
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Karen J. Wong
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Biying Xu
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Lawrence P. Szajek
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Osama Elbuluk
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Fabiola Cecchi
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Kristen Raffensperger
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Meghana Golla
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Donald P. Bottaro
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| | - Peter Choyke
- From the Molecular Imaging Program, National Cancer Institute (NCI), Bethesda, MD; ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Small Animal Imaging Program, NCI, Leidos Biomedical Research, Inc. (formerly SAIC-Frederick, Inc.), Frederick, MD; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Rockville, MD; PET Department, Clinical Center, NIH,
| |
Collapse
|